Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 209 | 290 | 342 | 234 | 369 |
| Gross Profit | 209 | 290 | 342 | 234 | 369 |
| Operating Expenses | 28,070 | 24,329 | 22,174 | 45,218 | 19,003 |
| Operating Income | -27,861 | -24,039 | -21,832 | -44,984 | -18,634 |
| Interest Expense | 65 | 119 | 128 | -73 | 69 |
| Other Income | 1,957 | 2,159 | 3,783 | 2,645 | 3,581 |
| Pre-tax Income | -25,969 | -21,999 | -18,177 | -42,266 | -15,122 |
| Net Income Continuous | -25,969 | -21,999 | -18,177 | -42,266 | -15,122 |
| Net Income Discontinuous | N/A | 514 | N/A | N/A | N/A |
| Net Income | $-25,969 | $-21,485 | $-18,177 | $-40,169 | $-15,122 |
| EPS Basic Total Ops | -0.35 | -0.29 | -0.25 | -0.59 | -0.21 |
| EPS Basic Continuous Ops | -0.35 | -0.30 | -0.25 | -0.60 | -0.21 |
| EPS Basic Discontinuous Ops | N/A | 0.01 | N/A | 0.01 | N/A |
| EPS Diluted Total Ops | -0.35 | -0.29 | -0.25 | -0.59 | -0.21 |
| EPS Diluted Continuous Ops | -0.35 | -0.30 | -0.25 | -0.60 | -0.21 |
| EPS Diluted Discontinuous Ops | N/A | 0.01 | N/A | 0.01 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.25 | N/A | -0.21 |
| EBITDA(a) | $-27,644 | $-24,081 | $-22,090 | $-20,820 | $-17,965 |